Lakeview Internal Medicine is categorized under Health Practitioners in Seneca, SC and active since 2000.
Lakeview Internal Medicine was established in 2000, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Practitioners business, which does work in the B2B market, and is classified as a Health Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Dora Fiorentino, Office Manager at the company’s single location by writing to 223 Main St, Seneca, South Carolina SC 29678 or by phoning (864) 985-1122. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lakeview Internal Medicine |
| Contact Person: | Dora Fiorentino, Office Manager |
| Address: | 223 Main St, Seneca, South Carolina 29678 |
| Phone Number: | (864) 985-1122 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Health Practitioners |
| SIC Code: | 8049 |
| NAICS Code: | 6211110 |
| Share This Business: |
Lakeview Internal Medicine was started in 2000 to provide professional Health Practitioners under the SIC code 8049 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Dora Fiorentino, Office Manager for inquiries that concern Lakeview Internal Medicine by calling the company number (864) 985-1122, as your correspondence is most welcome. Additionally, the physical location of the single location of Lakeview Internal Medicine can be found at the coordinates 34.68507,-82.95216 as well as the street address 223 Main St in Seneca, South Carolina 29678.
For its online presence, you may visit Lakeview Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.